From the Emergency Services edition of October 3, 2026
Powerful Medical and corpuls partner to embed Queen of Hearts AI ECG in prehospital corpuls devices (EU/UK/CH start)
Powerful Medical / corpuls · Prehospital EMS / cardiac emergency care technology · European Union, Switzerland, United Kingdom (stated launch); vendor claims global corpuls footprint in 70+ countries
- Publisher
- Powerful Medical
- Original publication
- 2026-10-01
- Source retrieved
- 2026-10-04
- Event date
- 2026-10-01
What happened
On October 1, 2026, Powerful Medical announced a partnership with corpuls to integrate the Queen of Hearts AI ECG model into corpuls monitor/defibrillator and telemedicine systems used by emergency professionals in over 70 countries, starting in the EU, Switzerland, and the United Kingdom. A 12-lead ECG on a corpuls3 would return STEMI and STEMI-equivalent (OMI) AI interpretation within seconds via corpuls.mission LIVE, with hospital PMcardio displaying the same finding for cath-lab readiness. The vendor states ~40% of occlusions lack classic ST-elevation; claims Queen of Hearts was trained on >2.5M angiographically labeled ECGs, doubles sensitivity vs STEMI criteria, reduces false cath-lab activations from 42% to 8%, and cites a Belgian prospective implementation cutting time-to-treatment by 48 minutes (STEMI-equivalent ~six hours sooner). FDA De Novo approval is highlighted on the site banner.
Why it matters
Prehospital EMS cardiac AI-ECG is squarely in emergency-services; U.S. SLED transferability limited until local device/regulatory paths and independent outcomes are shown.
Evidence and measured results
Vendor partnership press page with cited performance statistics and prior implementation claims; not an independent trial report.
Limitations and uncertainty
Vendor claims; EU/UK/CH start; Belgian/retrospective citations not re-audited here; FDA banner is not the same as this partnership’s geographic launch evidence.
Put this evidence to work
Lighthouse Advisory interpretation, grounded in this source. Enriched 2026-10-03; this does not change the original publication date. Each role follows the same checklist so takeaways compare across sources.
Sales
Role takeaway
- Customer problem
- Prehospital teams miss OMI without classic STEMI and over-activate cath labs on false STEMI criteria.
- Stakeholders
- EMS medical directors
- Paramedics
- Receiving cardiology/cath lab
- Device vendors
- Discovery questions
- Is corpuls already in the fleet?
- What is today’s false cath-lab activation rate?
- Who can override AI-ECG labels?
- Which geographies/regulatory clearances apply?
- Value hypothesis
- Embedded AI-ECG can reduce missed OMI and false activations if prospectively measured under medical-director governance.
- Potential engagement
- Clinical workflow workshop aligning AI-ECG alerts to local STEMI/OMI activation protocols.
- Unsupported claims
- Guaranteed 48-minute improvement from this release
- U.S. deployment readiness
- Zero missed OMI
Pre-sales engineering
Role takeaway
- Fit
- AI ECG interpretation embedded in prehospital monitor/defib and telemedicine path.
- Architecture and integration
- corpuls3 ECG → Queen of Hearts via mission LIVE → on-device result + hospital PMcardio.
- Prerequisites
- corpuls devices
- LIVE network
- Hospital PMcardio or equivalent
- Clinical protocol update
- Constraints
- EU/UK/CH start
- Vendor-claimed metrics
- Connectivity dependent
- Security
- ECG/PHI transmission via LIVE/telemedicine requires HIPAA/GDPR-equivalent controls and vendor BAAs.
- Proof of value
- False activation rate
- Missed OMI audits
- Contact-to-balloon under AI+human
Delivery
Role takeaway
- Work
- Enable LIVE AI path, train crews, align hospital notification, log outcomes back to EMS.
- Dependencies
- corpuls firmware/LIVE
- Hospital cardiology IT
- Medical direction
- Connectivity
- Ownership
- EMS medical director owns clinical use policy; vendors own model/device integration.
- Skills and adoption
- Train paramedics to treat AI labels as decision support with documented override.
- Governance checkpoints
- Medical-director approval
- False-activation review board
- Degraded-mode drill
- Acceptance criteria
- Override documented
- Outcome feedback loop live
- Activation KPI baseline set
- Risks
- Vendor-claim overfit
- Connectivity failure
- Alert fatigue
Implementation considerations
Lighthouse Advisory interpretation across the operating dimensions a public-sector buyer must settle before this evidence becomes a design. Each note answers the question under its heading for this specific source.
Architecture and integration
What must connect, and where does the AI sit in the workflow?
On-device/telemedicine AI ECG labels shared ambulance-to-hospital without separate hardware; depends on corpuls.mission LIVE connectivity.
Governance
Who approves, reviews and stays accountable for outcomes?
Clinical accept/reject of AI-OMI labels and cath-lab activation authority remain human medical-direction problems; partnership does not define liability allocation.
Security and privacy
What data, permissions and controls need testing?
Live ECG/PHI transmission to hospital platforms requires strong telemedicine security and data-processing agreements.
Accessibility and workforce
Who is affected, and what skills or accommodations follow?
Aims to put AI interpretation in paramedics’ existing device workflow rather than a separate app—reduces UI burden if training covers overrides.
Procurement
What should contracts, pricing and exit terms secure?
Hardware-locked to corpuls ecosystem; agencies not on corpuls face switching costs; demand independent clinical evidence packs in RFP.
Operating model
Which teams own the service once it runs?
Shifts some ECG triage judgment earlier in the EMS chain with hospital mirroring—requires joint EMS–cardiology protocols.
Publication history
- 2026-10-03Emergency Services · Issue 275 resources
Stable resource ID: powerfulmedical-corpuls-queen-of-hearts-20261001